更正“Celastrol诱导蛋白酶体降解FANCD2使肺癌细胞对DNA交联剂敏感”。

IF 4.5 2区医学 Q1 ONCOLOGY

Cancer Science Pub Date : 2025-03-29 DOI:10.1111/cas.70066

引用次数: 0

摘要

G.-Z。王,Y.-Q。Zhou，“Celastrol诱导蛋白酶体降解FANCD2使肺癌细胞对DNA交联剂敏感”，Cancer Science 106 (2015): 902-908, https://doi.org/10.1111/cas.12679.In图2b， Actin条带图像存在错误。图2b的正确图像如下所示：作者为错误道歉。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Correction to “Celastrol Induces Proteasomal Degradation of FANCD2 to Sensitize Lung Cancer Cells to DNA Crosslinking Agents”

G.-Z. Wang, Y.-Q. Liu, X. Cheng and G.-B. Zhou, “Celastrol Induces Proteasomal Degradation of FANCD2 to Sensitize Lung Cancer Cells to DNA Crosslinking Agents,” Cancer Science 106 (2015): 902–908, https://doi.org/10.1111/cas.12679.

In Figure 2b, there were errors in the images of the Actin bands. The correct images for Figure 2b are shown below:

The authors apologize for the error.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Cancer Science 医学-肿瘤学

自引率

3.50%

发文量

406

审稿时长

2 months

期刊介绍： Cancer Science (formerly Japanese Journal of Cancer Research) is a monthly publication of the Japanese Cancer Association. First published in 1907, the Journal continues to publish original articles, editorials, and letters to the editor, describing original research in the fields of basic, translational and clinical cancer research. The Journal also accepts reports and case reports. Cancer Science aims to present highly significant and timely findings that have a significant clinical impact on oncologists or that may alter the disease concept of a tumor. The Journal will not publish case reports that describe a rare tumor or condition without new findings to be added to previous reports; combination of different tumors without new suggestive findings for oncological research; remarkable effect of already known treatments without suggestive data to explain the exceptional result. Review articles may also be published.